Navigation Links
New Pill Shows Promise Against Relapsing Multiple Sclerosis
Date:9/19/2012

By Serena Gordon
HealthDay Reporter

WEDNESDAY, Sept. 19 (HealthDay News) -- A new pill can help prevent relapse in some people with multiple sclerosis (MS), new research indicates.

In two studies, the annualized relapse rate was cut nearly in half with twice-daily use of the new drug currently known as BG-12. One study also found that BG-12 could reduce the progression of disability, while the other study found no statistically significant difference between the drug and placebo for rates of disability.

"We found a robust reduction in the annualized relapse rate of 44 percent in the twice-daily group and 51 percent in the thrice-daily group," said Dr. Robert Fox, lead author of one of the studies and medical director at the Mellen Center for MS at the Cleveland Clinic, in Ohio.

Fox added that the drug was well tolerated in the clinical trial, and appears to be quite safe. "It's a pill they take twice a day at home, and there was no increased risk of opportunistic infections or cancer," he noted.

Results of the studies are published in the Sept. 20 issue of the New England Journal of Medicine. Both were funded by the drug's manufacturer, Biogen Idec.

Multiple sclerosis is an autoimmune disease that damages the outside of nerve fibers in the central nervous system, which includes the brain, spine and optic nerves, according to the National Multiple Sclerosis Society (NMSS). Symptoms can include fatigue, numbness in the limbs, balance and coordination problems, bladder or bowel dysfunction, vision problems, pain and even paralysis.

Most people -- about 85 percent -- have a form of MS that's called relapsing-remitting, according to the NMSS. That means that people have periods where the disease is very active. At other times, the disease remits. During these periods of remission, there may be complete or partial recovery of function, and the disease doesn't progress during remission.

B
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Drug Shows Promise Against Fragile X Syndrome, Possibly Autism
2. Infection data may not be comparable across hospitals, study shows
3. Cleveland Clinic study shows vitamin E may decrease cancer risk in Cowden syndrome patients
4. Study shows breath analysis could help diagnose pulmonary nodules
5. Water quality study shows need for testing at state migrant camps
6. Experimental Dengue Vaccine Shows Some Success
7. Molecule shows effectiveness against drug-resistant myeloma
8. Multiple Methods Can Safely Help Babies Get to Sleep, Study Shows
9. Large lung cancer study shows potential for more targeted therapies
10. Childhood virus RSV shows promise against adult cancer
11. Breast cancer screening saves lives, new study shows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New Pill Shows Promise Against Relapsing Multiple Sclerosis
(Date:5/18/2013)... Orlando, FL (May 18, 2013) There are ... procedures commonly used to diagnose or treat gastrointestinal ... Week (DDW). , A study by New ... that more objective testing may substantially reduce the ... (GERD). Although GERD is believed to affect nearly ...
(Date:5/18/2013)... Today, Zane Benefits, Inc. published ... in Marketplaces . Zane Benefits, which provides comprehensive ... benefits, is the leader in health care reform, ... arrangements . , According to Zane Benefits’ website, ... recently released a much-anticipated statement and Q&A on ...
(Date:5/18/2013)... York, NY (PRWEB) May 18, 2013 After ... consistent efforts, SizeItUp formally announced the integration of ... redesigned 2012 Hyundai Genesis is set to stun the automobile ... and style. 2012 Hyundai Genesis is marked as the latest ... and heads the vehicles lined up for the year 2013. ...
(Date:5/18/2013)... May 18, 2013 Although obesity is ... the association between obesity and esophageal adenocarcinoma, a type ... obesity-related tumors. As reported on Cancer.gov, last ... almost twice as likely as those of normal and ... relationship between obesity and esophageal cancer is not well ...
(Date:5/18/2013)... TX (PRWEB) May 18, 2013 Show And ... years of various different training systems that is all about ... has caught the attention of http://ShowAndGoTrainingReview.com ’s Stan ... Training is a unique “four phase system” designed to ... minimum amount of time spent working out in the gym. ...
Breaking Medicine News(10 mins):Health News:New research identifies practice changes to improve value and quality of GI procedures 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Renowned Rim Fitments Provider SizeItUp Launched Database Integrations for the 2012 Hyundai Genesis 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Show And Go Training: Review Examining Eric Cressy's Workout Program Revealed 2
... XLHealth, owner of one of the nation,s largest Medicare ... improving the quality of care for seniors with chronic ... to serve as its vice president of contracting and ... for the establishment, strategic planning, and management for the ...
... 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), the ... Phase 3b study that found VYVANSE (lisdexamfetamine dimesylate) CII ... a simulated workplace environment study in adults with Attention ... approved stimulant for adults with ADHD to be evaluated ...
... , Partnership to Fund $240 Million in New Services, ... , , MANASSAS, Va. and WINSTON-SALEM, N.C. ... the Federal Trade Commission and the Virginia Attorney General, ... Novant Health of North Carolina, both non-profit organizations, announced ...
... Christian Children,s Fund, one of the world,s ... The new name takes effect today. , , ... strategy to meet the needs of children today and tomorrow. ... million children and family members in 31 countries. , ...
... , Unified Blue Cross Blue Shield Brand Strengthens Competitive Position , ... Virgin Islands , , SAN JUAN, Puerto ... GTS ) today announced that Triple-S Salud, Inc., its managed ... assets of La Cruz Azul de Puerto Rico, Inc. for approximately $10.5 ...
... Web-Based Fraud Prevention Tools Can Reduce Medical Identity Theft , ... Corporation , a leading provider of data enhancement, verification, ... to assist health care organizations prepare for enforcement of the ... , (Logo: http://www.newscom.com/cgi-bin/prnh/20090701/PH40278LOGO ) , , According ...
Cached Medicine News:Health News:XLHealth Appoints New Vice President of Contracting and Provider Relations 2Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 2Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 3Health News:VYVANSE CII provided significant efficacy at 14 hours in adults with ADHD 4Health News:Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 2Health News:Prince William Health System Completes Merger With Novant Health to Expand Quality Health Care in Northern Virginia 3Health News:Christian Children's Fund Name Change to ChildFund International Official 2Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 2Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 3Health News:Triple-S Management Corporation Completes Acquisition of La Cruz Azul de Puerto Rico, Inc. 4Health News:CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 2Health News:CDYNE XML Web Services Help Organizations Comply with FTC Red Flags Rule 3
(Date:5/17/2013)... JERUSALEM , May 17, 2013 ... a developer of oral drug delivery systems, announced today ... has cleared the Company,s Investigational New Drug application(IND) for ... very pleased to have the FDA clearance to proceed," ... Oramed. "The upcoming trial is a major milestone for ...
(Date:5/17/2013)... , May 17, 2013  Boston Scientific Corporation ... at the annual EuroPCR Scientific Program May 21-24 in ... pleased to present a particularly rich and diversified set ... Keith Dawkins , M.D., global chief medical officer, ... will be presented, including the NG PROMUS trial, which ...
(Date:5/16/2013)... MECHELEN, Belgium , May 17, 2013 ... ABBV ) announced today an extension of ... Galapagos will fund and complete a Phase 2 program ... progression into Phase 3.  Upon successful completion of the ... $50 million.  The terms of the collaboration extension are ...
Breaking Medicine Technology:Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 2Oramed Receives FDA Clearance to Initiate Oral Insulin Trials in the U.S. 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 2Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 3Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 4Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 5Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 6Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 7Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 8AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 2AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 3AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 4AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 5AbbVie and Galapagos Extend GLPG0634 Collaboration to Include Crohn's Disease 6
... (Nasdaq: HOLX ) today announced that Rob ... the 2010 Morgan Stanley Global Healthcare Conference on Tuesday, ... Interested parties are invited to listen to the live ... section of the company,s website at www.hologic.com/investors-overview . ...
... Fall Conference at Maui, Hawaii From September 1 -... -- CHENGDU, China, Aug. 30 /PRNewswire-Asia-FirstCall/ -- ... ... lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so ...
Cached Medicine Technology:Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 2Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 3Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 4Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 5Tianyin To Attend ROTH Fall Conference at Maui, Hawaii From September 1 - September 6 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: